About David Mahoney
David Mahoney is the former co-CEO of McKesson HBOC, Inc. and CEO of iMcKesson LLC from July 1999 to February 2001. Mahoney joined McKesson in 1990 as vice president for Strategic Planning, and was responsible for planning and corporate development. He had overall responsibility for McKesson's strategic relations with pharmaceutical and biotechnology companies, was responsible for the establishment of the Pharmaceutical Partners Group at McKesson, and the launch of a new generics program. Prior to joining McKesson, Mahoney was a principal with McKinsey & Company from 1981 to 1990. He serves on the board of directors of Corcept Therapeutics, Inc., KQED, SFMOMA, and Mercy Corps. Mr. Mahoney has a bachelor's degree from Princeton University and a master's of business administration from Harvard University.
Want to inform investors similar to David Mahoney about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest David Mahoney News
Sep 8, 2022
»London Bridge is down!« »London Bridge is down!« »London Bridge is down!«… God Save the Queen God Save the King God Save The Fall of the House of Cabal Schumann Resonance Today ⚡️ 61 Hrs Blackout – Disclosure News… This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.
David Mahoney Investments
David Mahoney has made 2 investments. Their latest investment was in about.me as part of their Seed VC on December 12, 2009.
David Mahoney Investments Activity